United States · FDA National Drug Code directory

DABIGATRAN ETEXILATE MESYLATE

Source ingredient · 50 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 67877-475_d2fd635f-6c0f-4509-8c91-348c1b73ca45

Dabigatran Etexilate

CAPSULE, COATED PELLETS / Ascend Laboratories, LLC

United States · Source reference 67877-624_d2fd635f-6c0f-4509-8c91-348c1b73ca45

Dabigatran Etexilate

CAPSULE, COATED PELLETS / Ascend Laboratories, LLC

United States · Source reference 72603-239_450cc975-a89f-2a41-e063-6394a90aefcf

Dabigatran Etexilate

CAPSULE / NorthStar RxLLC

United States · Source reference 72865-272_3f2f2d85-443a-46a1-a637-69b106156df4

Dabigatran Etexilate

CAPSULE / XLCare Pharmaceuticals, Inc.

United States · Source reference 72865-273_3f2f2d85-443a-46a1-a637-69b106156df4

Dabigatran Etexilate

CAPSULE / XLCare Pharmaceuticals, Inc.

United States · Source reference 43598-453_e9e8ec3b-2d7e-31cc-6268-60e4da2236ba

Dabigatran etexilate

CAPSULE / Dr.Reddys Laboratories Inc

United States · Source reference 43598-641_e9e8ec3b-2d7e-31cc-6268-60e4da2236ba

Dabigatran etexilate

CAPSULE / Dr.Reddys Laboratories Inc

United States · Source reference 43598-642_e9e8ec3b-2d7e-31cc-6268-60e4da2236ba

Dabigatran etexilate

CAPSULE / Dr.Reddys Laboratories Inc

United States · Source reference 0597-0108_ecf1aa06-c610-4fdb-a380-2e716d7e63c2

Pradaxa

CAPSULE / Boehringer Ingelheim Pharmaceuticals Inc.

United States · Source reference 0597-0355_ecf1aa06-c610-4fdb-a380-2e716d7e63c2

Pradaxa

CAPSULE / Boehringer Ingelheim Pharmaceuticals Inc.

United States · Source reference 0597-0360_ecf1aa06-c610-4fdb-a380-2e716d7e63c2

Pradaxa

CAPSULE / Boehringer Ingelheim Pharmaceuticals Inc.

United States · Source reference 0597-0425_56b1a7c2-0afd-40c6-bda5-563e234a9f28

Pradaxa

PELLET / Boehringer Ingelheim Pharmaceuticals, Inc.

United States · Source reference 0597-0430_56b1a7c2-0afd-40c6-bda5-563e234a9f28

Pradaxa

PELLET / Boehringer Ingelheim Pharmaceuticals, Inc.

United States · Source reference 0597-0435_56b1a7c2-0afd-40c6-bda5-563e234a9f28

Pradaxa

PELLET / Boehringer Ingelheim Pharmaceuticals, Inc.

United States · Source reference 0597-0440_56b1a7c2-0afd-40c6-bda5-563e234a9f28

Pradaxa

PELLET / Boehringer Ingelheim Pharmaceuticals, Inc.

United States · Source reference 0597-0445_56b1a7c2-0afd-40c6-bda5-563e234a9f28

Pradaxa

PELLET / Boehringer Ingelheim Pharmaceuticals, Inc.

United States · Source reference 0597-0450_56b1a7c2-0afd-40c6-bda5-563e234a9f28

Pradaxa

PELLET / Boehringer Ingelheim Pharmaceuticals, Inc.

United States · Source reference 60505-4347_a6e65f41-054f-4c6a-dc8d-ec2fd71a6c79

dabigatran etexilate

CAPSULE / Apotex Corp.

United States · Source reference 60505-4348_a6e65f41-054f-4c6a-dc8d-ec2fd71a6c79

dabigatran etexilate

CAPSULE / Apotex Corp.

United States · Source reference 60505-4349_a6e65f41-054f-4c6a-dc8d-ec2fd71a6c79

dabigatran etexilate

CAPSULE / Apotex Corp.

Browse ingredients in United States →